Mutation Clearance after Transplantation for Myelodysplastic Syndrome
Eric J. Duncavage(Washington University in St. Louis), Matthew J. Walter(MACOM (United States)), Iskra Pusic(Washington University in St. Louis), Natasha Edwin(Washington University in St. Louis), Raya Saba(Saint Louis University Hospital), Kathryn Trinkaus(Washington University in St. Louis), Daniel C. Link(Washington University in St. Louis), Catrina C. Fronick(Washington University in St. Louis), Joshua D. Robinson(Washington University in St. Louis), Timothy A. Graubert(Massachusetts General Hospital), Robert S. Fulton(St. Jude Children's Research Hospital), Haley Abel(Washington University in St. Louis), John F. DiPersio(Washington University in St. Louis), Gue Su Chang(James S. McDonnell Foundation), Lukas D. Wartman(MACOM (United States)), Timothy J. Ley(Washington University in St. Louis), John S. Welch(Washington University in St. Louis), Kimberly Brendel(Washington University in St. Louis), Michelle D. O’Laughlin(Washington University in St. Louis), Geoffrey L. Uy(Memorial Sloan Kettering Cancer Center), Christopher A. Miller(Washington University in St. Louis), Sharon E. Heath(MACOM (United States)), Peter Westervelt(MACOM (United States)), Kevin Elliott(Washington University in St. Louis), Matthew Christopher(Washington University in St. Louis), Meagan A. Jacoby(MACOM (United States)), Jin Shao(Washington University in St. Louis)
Cited by 121
Related Papers
The complete sequence of a human genome
|Science|2022|3.3k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML
|New England Journal of Medicine|2018|1.4k
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k